Long-Term Persistence of Ciprofloxacin-Resistant Haemophilus influenzae in Patients with Cystic Fibrosis

Ciprofloxacin has been a major advance in the treatment of chronic respiratory infections. Three patients with cystic fibrosis and colonized by 5 nontypeable Haemophilus influenzae strains exhibiting low- (MIC, 2 µg/mL) and high-level ciprofloxacin resistance (MICs, 16-32 µg/mL) are described. The p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 1996-12, Vol.174 (6), p.1345-1347
Hauptverfasser: Campos, José, Román, Federico, Georgiou, Marios, García, Concepción, Gómez-Lus, Rafael, Cantón, Rafael, Escobar, Hector, Baquero, Fernando
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1347
container_issue 6
container_start_page 1345
container_title The Journal of infectious diseases
container_volume 174
creator Campos, José
Román, Federico
Georgiou, Marios
García, Concepción
Gómez-Lus, Rafael
Cantón, Rafael
Escobar, Hector
Baquero, Fernando
description Ciprofloxacin has been a major advance in the treatment of chronic respiratory infections. Three patients with cystic fibrosis and colonized by 5 nontypeable Haemophilus influenzae strains exhibiting low- (MIC, 2 µg/mL) and high-level ciprofloxacin resistance (MICs, 16-32 µg/mL) are described. The patients had received several courses of ciprofloxacin. These MICs represent a decrease in ciprofloxacin susceptibility of 200-3200 times. Molecular epidemiologic methods demonstrated that 2 patients were chronically colonized by their own ciprofloxacin-resistant strains for ⩾ 15-17 months. Three strains showed simultaneous resistance to ampicillin and chloramphenicol by enzyme inactivation, and 2 had ampicillin resistance without β-lactamase activity. These data suggest that the emergence and long-term persistence of ciprofloxacin-resistant H. infiuenzae in patients with cystic fibrosis can be a consequence of antibiotic treatment.
doi_str_mv 10.1093/infdis/174.6.1345
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_78572032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30129971</jstor_id><sourcerecordid>30129971</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-5f4db3ee85fc7ca4f29ee22ed57c8ab0bd3abe74b60d8339ed544d0f554d95fa3</originalsourceid><addsrcrecordid>eNqFkV2LEzEUhoMoa3f1B3ghBC-8m24-J8mlFHcrFFzLCuJNyMyc2NT5qMkM7vrrN0NLBW-8SuB535McHoTeULKkxPDr0PsmpGuqxLJcUi7kM7SgkquiLCl_jhaEMFZQbcxLdJnSnhAieKku0IU2gjBOF2i3GfofxT3EDt9BTCGN0NeAB49X4RAH3w4Prg59sYWZuX7EawfdcNiFdko4v99O0P9xkK_4zo0B-jHh32Hc4dVjGkONb0IVh9x9hV541yZ4fTqv0Nebj_erdbH5fPtp9WFT1EKqsZBeNBUH0NLXqnbCMwPAGDRS1dpVpGq4q0CJqiSN5txkIERDvJSiMdI7foXeH-fm3_-aII22C6mGtnU9DFOySkvFCGf_DVKpheJc5-C7f4L7YYp9XsIyxg0jquQ5RI-hOm-bInh7iKFz8dFSYmdX9ujKZle2tLOr3Hl7GjxVHTTnxknOX75P4xDPmBPKjFEzL458tvZw5i7-tKXiStr1t-_2y3arzfpWW8afAM9sq8c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223920763</pqid></control><display><type>article</type><title>Long-Term Persistence of Ciprofloxacin-Resistant Haemophilus influenzae in Patients with Cystic Fibrosis</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Campos, José ; Román, Federico ; Georgiou, Marios ; García, Concepción ; Gómez-Lus, Rafael ; Cantón, Rafael ; Escobar, Hector ; Baquero, Fernando</creator><creatorcontrib>Campos, José ; Román, Federico ; Georgiou, Marios ; García, Concepción ; Gómez-Lus, Rafael ; Cantón, Rafael ; Escobar, Hector ; Baquero, Fernando</creatorcontrib><description>Ciprofloxacin has been a major advance in the treatment of chronic respiratory infections. Three patients with cystic fibrosis and colonized by 5 nontypeable Haemophilus influenzae strains exhibiting low- (MIC, 2 µg/mL) and high-level ciprofloxacin resistance (MICs, 16-32 µg/mL) are described. The patients had received several courses of ciprofloxacin. These MICs represent a decrease in ciprofloxacin susceptibility of 200-3200 times. Molecular epidemiologic methods demonstrated that 2 patients were chronically colonized by their own ciprofloxacin-resistant strains for ⩾ 15-17 months. Three strains showed simultaneous resistance to ampicillin and chloramphenicol by enzyme inactivation, and 2 had ampicillin resistance without β-lactamase activity. These data suggest that the emergence and long-term persistence of ciprofloxacin-resistant H. infiuenzae in patients with cystic fibrosis can be a consequence of antibiotic treatment.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/174.6.1345</identifier><identifier>PMID: 8940231</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Adult ; Ampicillin Resistance ; Anti-Infective Agents - therapeutic use ; Antibiotics ; beta-Lactamases - metabolism ; Chloramphenicol Resistance ; Ciprofloxacin - therapeutic use ; Concise Communication ; Cystic fibrosis ; Cystic Fibrosis - microbiology ; Drug Resistance, Microbial ; Electrophoresis, Gel, Pulsed-Field ; Female ; Fluoroquinolones ; Gels ; Haemophilus ; Haemophilus Infections - drug therapy ; Haemophilus influenzae ; Haemophilus influenzae - drug effects ; Haemophilus influenzae - growth &amp; development ; Humans ; Infections ; Male ; Microbial Sensitivity Tests ; Microbiology ; Molecular Epidemiology ; Polymorphism, Restriction Fragment Length ; Quinolones ; Sputum</subject><ispartof>The Journal of infectious diseases, 1996-12, Vol.174 (6), p.1345-1347</ispartof><rights>Copyright 1996 The University of Chicago</rights><rights>Copyright University of Chicago, acting through its Press Dec 1996</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-5f4db3ee85fc7ca4f29ee22ed57c8ab0bd3abe74b60d8339ed544d0f554d95fa3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30129971$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30129971$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27922,27923,58015,58248</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8940231$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Campos, José</creatorcontrib><creatorcontrib>Román, Federico</creatorcontrib><creatorcontrib>Georgiou, Marios</creatorcontrib><creatorcontrib>García, Concepción</creatorcontrib><creatorcontrib>Gómez-Lus, Rafael</creatorcontrib><creatorcontrib>Cantón, Rafael</creatorcontrib><creatorcontrib>Escobar, Hector</creatorcontrib><creatorcontrib>Baquero, Fernando</creatorcontrib><title>Long-Term Persistence of Ciprofloxacin-Resistant Haemophilus influenzae in Patients with Cystic Fibrosis</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Ciprofloxacin has been a major advance in the treatment of chronic respiratory infections. Three patients with cystic fibrosis and colonized by 5 nontypeable Haemophilus influenzae strains exhibiting low- (MIC, 2 µg/mL) and high-level ciprofloxacin resistance (MICs, 16-32 µg/mL) are described. The patients had received several courses of ciprofloxacin. These MICs represent a decrease in ciprofloxacin susceptibility of 200-3200 times. Molecular epidemiologic methods demonstrated that 2 patients were chronically colonized by their own ciprofloxacin-resistant strains for ⩾ 15-17 months. Three strains showed simultaneous resistance to ampicillin and chloramphenicol by enzyme inactivation, and 2 had ampicillin resistance without β-lactamase activity. These data suggest that the emergence and long-term persistence of ciprofloxacin-resistant H. infiuenzae in patients with cystic fibrosis can be a consequence of antibiotic treatment.</description><subject>Adult</subject><subject>Ampicillin Resistance</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>beta-Lactamases - metabolism</subject><subject>Chloramphenicol Resistance</subject><subject>Ciprofloxacin - therapeutic use</subject><subject>Concise Communication</subject><subject>Cystic fibrosis</subject><subject>Cystic Fibrosis - microbiology</subject><subject>Drug Resistance, Microbial</subject><subject>Electrophoresis, Gel, Pulsed-Field</subject><subject>Female</subject><subject>Fluoroquinolones</subject><subject>Gels</subject><subject>Haemophilus</subject><subject>Haemophilus Infections - drug therapy</subject><subject>Haemophilus influenzae</subject><subject>Haemophilus influenzae - drug effects</subject><subject>Haemophilus influenzae - growth &amp; development</subject><subject>Humans</subject><subject>Infections</subject><subject>Male</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology</subject><subject>Molecular Epidemiology</subject><subject>Polymorphism, Restriction Fragment Length</subject><subject>Quinolones</subject><subject>Sputum</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV2LEzEUhoMoa3f1B3ghBC-8m24-J8mlFHcrFFzLCuJNyMyc2NT5qMkM7vrrN0NLBW-8SuB535McHoTeULKkxPDr0PsmpGuqxLJcUi7kM7SgkquiLCl_jhaEMFZQbcxLdJnSnhAieKku0IU2gjBOF2i3GfofxT3EDt9BTCGN0NeAB49X4RAH3w4Prg59sYWZuX7EawfdcNiFdko4v99O0P9xkK_4zo0B-jHh32Hc4dVjGkONb0IVh9x9hV541yZ4fTqv0Nebj_erdbH5fPtp9WFT1EKqsZBeNBUH0NLXqnbCMwPAGDRS1dpVpGq4q0CJqiSN5txkIERDvJSiMdI7foXeH-fm3_-aII22C6mGtnU9DFOySkvFCGf_DVKpheJc5-C7f4L7YYp9XsIyxg0jquQ5RI-hOm-bInh7iKFz8dFSYmdX9ujKZle2tLOr3Hl7GjxVHTTnxknOX75P4xDPmBPKjFEzL458tvZw5i7-tKXiStr1t-_2y3arzfpWW8afAM9sq8c</recordid><startdate>19961201</startdate><enddate>19961201</enddate><creator>Campos, José</creator><creator>Román, Federico</creator><creator>Georgiou, Marios</creator><creator>García, Concepción</creator><creator>Gómez-Lus, Rafael</creator><creator>Cantón, Rafael</creator><creator>Escobar, Hector</creator><creator>Baquero, Fernando</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19961201</creationdate><title>Long-Term Persistence of Ciprofloxacin-Resistant Haemophilus influenzae in Patients with Cystic Fibrosis</title><author>Campos, José ; Román, Federico ; Georgiou, Marios ; García, Concepción ; Gómez-Lus, Rafael ; Cantón, Rafael ; Escobar, Hector ; Baquero, Fernando</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-5f4db3ee85fc7ca4f29ee22ed57c8ab0bd3abe74b60d8339ed544d0f554d95fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Ampicillin Resistance</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>beta-Lactamases - metabolism</topic><topic>Chloramphenicol Resistance</topic><topic>Ciprofloxacin - therapeutic use</topic><topic>Concise Communication</topic><topic>Cystic fibrosis</topic><topic>Cystic Fibrosis - microbiology</topic><topic>Drug Resistance, Microbial</topic><topic>Electrophoresis, Gel, Pulsed-Field</topic><topic>Female</topic><topic>Fluoroquinolones</topic><topic>Gels</topic><topic>Haemophilus</topic><topic>Haemophilus Infections - drug therapy</topic><topic>Haemophilus influenzae</topic><topic>Haemophilus influenzae - drug effects</topic><topic>Haemophilus influenzae - growth &amp; development</topic><topic>Humans</topic><topic>Infections</topic><topic>Male</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology</topic><topic>Molecular Epidemiology</topic><topic>Polymorphism, Restriction Fragment Length</topic><topic>Quinolones</topic><topic>Sputum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Campos, José</creatorcontrib><creatorcontrib>Román, Federico</creatorcontrib><creatorcontrib>Georgiou, Marios</creatorcontrib><creatorcontrib>García, Concepción</creatorcontrib><creatorcontrib>Gómez-Lus, Rafael</creatorcontrib><creatorcontrib>Cantón, Rafael</creatorcontrib><creatorcontrib>Escobar, Hector</creatorcontrib><creatorcontrib>Baquero, Fernando</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Campos, José</au><au>Román, Federico</au><au>Georgiou, Marios</au><au>García, Concepción</au><au>Gómez-Lus, Rafael</au><au>Cantón, Rafael</au><au>Escobar, Hector</au><au>Baquero, Fernando</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term Persistence of Ciprofloxacin-Resistant Haemophilus influenzae in Patients with Cystic Fibrosis</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1996-12-01</date><risdate>1996</risdate><volume>174</volume><issue>6</issue><spage>1345</spage><epage>1347</epage><pages>1345-1347</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>Ciprofloxacin has been a major advance in the treatment of chronic respiratory infections. Three patients with cystic fibrosis and colonized by 5 nontypeable Haemophilus influenzae strains exhibiting low- (MIC, 2 µg/mL) and high-level ciprofloxacin resistance (MICs, 16-32 µg/mL) are described. The patients had received several courses of ciprofloxacin. These MICs represent a decrease in ciprofloxacin susceptibility of 200-3200 times. Molecular epidemiologic methods demonstrated that 2 patients were chronically colonized by their own ciprofloxacin-resistant strains for ⩾ 15-17 months. Three strains showed simultaneous resistance to ampicillin and chloramphenicol by enzyme inactivation, and 2 had ampicillin resistance without β-lactamase activity. These data suggest that the emergence and long-term persistence of ciprofloxacin-resistant H. infiuenzae in patients with cystic fibrosis can be a consequence of antibiotic treatment.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>8940231</pmid><doi>10.1093/infdis/174.6.1345</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1996-12, Vol.174 (6), p.1345-1347
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_78572032
source MEDLINE; JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current)
subjects Adult
Ampicillin Resistance
Anti-Infective Agents - therapeutic use
Antibiotics
beta-Lactamases - metabolism
Chloramphenicol Resistance
Ciprofloxacin - therapeutic use
Concise Communication
Cystic fibrosis
Cystic Fibrosis - microbiology
Drug Resistance, Microbial
Electrophoresis, Gel, Pulsed-Field
Female
Fluoroquinolones
Gels
Haemophilus
Haemophilus Infections - drug therapy
Haemophilus influenzae
Haemophilus influenzae - drug effects
Haemophilus influenzae - growth & development
Humans
Infections
Male
Microbial Sensitivity Tests
Microbiology
Molecular Epidemiology
Polymorphism, Restriction Fragment Length
Quinolones
Sputum
title Long-Term Persistence of Ciprofloxacin-Resistant Haemophilus influenzae in Patients with Cystic Fibrosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T08%3A38%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20Persistence%20of%20Ciprofloxacin-Resistant%20Haemophilus%20influenzae%20in%20Patients%20with%20Cystic%20Fibrosis&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Campos,%20Jos%C3%A9&rft.date=1996-12-01&rft.volume=174&rft.issue=6&rft.spage=1345&rft.epage=1347&rft.pages=1345-1347&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/174.6.1345&rft_dat=%3Cjstor_proqu%3E30129971%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223920763&rft_id=info:pmid/8940231&rft_jstor_id=30129971&rfr_iscdi=true